FrancophonIA/ELRC3.0 huggingface dataset:
English: Posology in patients not adequately controlled with aliskiren or amlodipine monotherapy Rasilamlo 300 mg/10 mg may be administered in patients whose blood pressure is not adequately controlled with aliskiren 300 mg or amlodipine 10 mg alone or Rasilamlo 150 mg/10 mg or
Croatian: Doziranje u bolesnika neodgovarajuće kontroliranih monoterapijom aliskirenom ili amlodipinom Rasilamlo 300 mg/10 mg se može primjeniti u bolesnika čiji krvni tlak nije odgovarajuće kontroliran samo aliskirenom 300 mg ili samo amlodipinom 10 mg ili Rasilamlom 150 mg/10 mg ili Rasilamlom 300 mg/5 mg.
English: Posology in patients not adequately controlled with aliskiren or amlodipine monotherapy Rasilamlo 150 mg/10 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 10 mg alone or with Rasilamlo 150 mg/5 mg.
Croatian: Doziranje u bolesnika neodgovarajuće kontroliranih monoterapijom aliskirenom ili amlodipinom Rasilamlo 150 mg/10 mg se može primjeniti u bolesnika čiji krvni tlak nije odgovarajuće kontroliran samo amlodipinom 10 mg ili s Rasilamlom 150 mg/5 mg.
English: Tablet core
Croatian: Bol u prsištu
English: Haemoglobin decreased a, haematocrit decreased a,
Croatian: Sniženi hemoglobin a, sniženi hematokrit a,
English: - Each Rasilamlo 150 mg/5 mg film-coated tablet contains 150 mg aliskiren (as hemifumarate) and 5 mg amlodipine (as besylate).
Croatian: Što Rasilamlo sadrži - Svaka Rasilamlo 150 mg/5 mg filmom obložena tableta sadrži 150 mg aliskirena (u obliku aliskirenhemifumarata) i 5 mg amlodipina (u obliku amlodipinbesilata).
English: • severe upper stomach pain
Croatian: • jaka bol u gornjem dijelu trbuha
English: , increased urinary frequency
Croatian: • povišeni jetreni enzimi
English: Smaller changes in furosemide pharmacokinetics and efficacy were
Croatian: Manje promjene u farmakokinetici i djelotvornosti furosemida bile su opažene uz aliskiren 150 mg/dan.
English: Each film-coated tablet contains 300 mg aliskiren (as hemifumarate) and 10 mg amlodipine (as besylate).
Croatian: Svaka filmom obložena tableta sadrži 300 mg aliskirena (u obliku aliskirenhemifumarata) i 10 mg amlodipina (u obliku amlodipinbesilata).
English: , exanthema
Croatian: , astenija
English: Each film-coated tablet contains 150 mg aliskiren (as hemifumarate) and 5 mg amlodipine (as besylate).
Croatian: Svaka filmom obložena tableta sadrži 150 mg aliskirena (u obliku aliskirenhemifumarata) i 5 mg amlodipina (u obliku amlodipinbesilata).
English: Respiratory, thoracic and mediastinal disorders
Croatian: digoksina, varfarina ili ciklosporina.
English: Each film-coated tablet contains 300 mg aliskiren (as hemifumarate) and 5 mg amlodipine (as besylate).
Croatian: Svaka filmom obložena tableta sadrži 300 mg aliskirena (u obliku aliskirenhemifumarata) i 5 mg amlodipina (u obliku amlodipinbesilata).
English: Each film-coated tablet contains 150 mg aliskiren (as hemifumarate) and 10 mg amlodipine (as besylate).
Croatian: Svaka filmom obložena tableta sadrži 150 mg aliskirena (u obliku aliskirenhemifumarata) i 10 mg amlodipina (u obliku amlodipinbesilata).
English: Brown-yellow, convex, ovaloid tablet with a bevelled edge, with “T12” debossed on one side and
Croatian: Smeđe-žuta, konveksna, ovalna tableta s kosim rubovima, s utisnutom oznakom „T12“ na jednoj i „NVR“ na drugoj strani.
English: , malaise
Croatian: • smetenost
English: • trembling
Croatian: • omaglica
English: , nausea a,am
Croatian: , mučnina a,am
English: , asthenia
Croatian: Liječenje
English: In post-marketing experience, renal dysfunction and cases of acute renal failure have been reported in
Croatian: Nakon stavljanja lijeka u promet u rizičnih bolesnika prijavljena je disfunkcija bubrega i slučajevi akutnog zatajenja bubrega (vidjeti dio 4.4).
English: Novartis Pharma Services Inc. Tel: +372 66 30 810
Croatian: Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00
English: , jaundice a,am
Croatian: , žutica a,am
English: Dyspnoea a, am
Croatian: Omaglica a,am
English: What Rasilamlo looks like and contents of the pack Rasilamlo 150 mg/5 mg film-coated tablets are light yellow, convex, oval film-coated tablets, with “T2” debossed on one side and “NVR” on the other.
Croatian: Rasilamlo 150 mg/5 mg filmom obložene tablete su svijetlo žute, konveksne, ovalne filmom obložene tablete, s utisnutom oznakom „T2“ na jednoj i „NVR“ na drugoj strani.
English: Each tablet contains 300 mg aliskiren (as aliskiren hemifumarate) and 10 mg amlodipine (as
Croatian: Jedna tableta sadrži 300 mg aliskirena (u obliku aliskirenhemifumarata) i 10 mg amlodipina (u obliku amlodipinbesilata).
English: Each tablet contains 300 mg aliskiren (as aliskiren hemifumarate) and 5 mg amlodipine (as
Croatian: Jedna tableta sadrži 300 mg aliskirena (u obliku aliskirenhemifumarata) i 5 mg amlodipina (u obliku amlodipinbesilata).
English: Each tablet contains 150 mg aliskiren (as aliskiren hemifumarate) and 10 mg amlodipine (as
Croatian: Jedna tableta sadrži 150 mg aliskirena (u obliku aliskirenhemifumarata) i 10 mg amlodipina (u obliku amlodipinbesilata).
English: Each tablet contains 150 mg aliskiren (as aliskiren hemifumarate) and 5 mg amlodipine (as
Croatian: Jedna tableta sadrži 150 mg aliskirena (u obliku aliskirenhemifumarata) i 5 mg amlodipina (u obliku amlodipinbesilata).
English: Light yellow, convex, ovaloid tablet with a bevelled edge, with “T2” debossed on one side and
Croatian: Svijetložuta, konveksna, ovalna tableta s kosim rubovima, s utisnutom oznakom „T2“ na jednoj i „NVR“ na drugoj strani.
English: - if you are taking either of the following classes of medicines used to treat high blood pressure: an angiotensin converting enzyme inhibitor such as enalapril, lisinopril, ramipril an angiotensin II receptor blocker such as valsartan, telmisartan, irbesartan - if you have diabetes (high blood sugar)
Croatian: Obavijestite svog liječnika ako uzimate neki od sljedećih lijekova: - blokator angiotenzina II receptora (ARB) ili inhibitor angiotenzin - konvertirajućeg enzima,
English: (4) Not statistically significant.
Croatian: (4) nije statistički značajno
English: Incidence per 100,000 person years
Croatian: Incidencija na 100 000 osoba-godine
English: Children above 5 years old
Croatian: Djeca starija od 5 godina
English: These reactions will usually occur before leaving the doctor's surgery.
Croatian: Te se reakcije obično pojave prije nego što napustite liječničku ordinaciju.
English: However, talk to your doctor first.
Croatian: Međutim, prvo se posavjetujte s liječnikom.
English: For adsorbent, see section 2.
Croatian: Za adsorbens, vidjeti dio 2.
English: Type or cause of AOM
Croatian: Vrsta ili uzrok AOM-a
English: • unusual crying
Croatian: • neuobičajen plač
English: This does not constitute a sign of deterioration.
Croatian: Ovo nije znak kvarenja.
English: The majority of these reactions were of mild to moderate severity and were not long lasting.
Croatian: Većina ovih reakcija bile su blage do umjerene težine te nisu dugo trajale.
English: This is so that you and your doctor can talk about what steps need to be taken to protect your child.
Croatian: Vi i liječnik trebate se dogovoriti koje korake treba poduzeti u svrhu zaštite Vašeg djeteta.
English: If your child misses an injection
Croatian: Ako Vaše dijete propusti injekciju
English: The results were not statistically significant across all analyses in COMPAS.
Croatian: Rezultati nisu bili statistički značajni u svim analizama u sklopu ispitivanja COMPAS.
English: Efficacy and effectiveness in clinical trials
Croatian: Djelotvornost i učinkovitost u kliničkim ispitivanjima
English: Remove the needle protector, which on occasion can be a little stiff.
Croatian: Odstranite zaštitu za iglu što ponekad može ići malo teže.
English: Acute Otitis Media (AOM)
Croatian: Akutni otitis media (AOM)
English: • allergic reactions such as skin allergies
Croatian: • alergijske reakcije kao što su kožne alergije
English: • You will be told when your child should come back for the next injections.
Croatian: • Reći će Vam kada trebate dovesti dijete za sljedeće injekcije.
English: In addition, OPA GMTs were in same ranges for both groups.
Croatian: Također, OPA GMT su bili u istom rasponu za obje skupine.
English: Effectiveness in post-marketing surveillance
Croatian: Učinkovitost u postmarketinškom praćenju
English: Bacteria can be responsible for 60-70% of clinical episodes of AOM.
Croatian: Bakterije mogu biti odgovorne za 60 - 70% kliničkih epizoda AOM-a.
English: If this applies to your child then the vaccination will be postponed until your child is feeling better.
Croatian: Ako se ovo odnosi na Vaše dijete, cijepljenje se odlaže dok Vaše dijete ne bude bolje.
English: • This vaccine has been prescribed for your child only.
Croatian: • Ovo je cjepivo propisano samo Vašem djetetu.
English: Control vaccine N=10,201
Croatian: Kontrolno cjepivo N=10 201
English: The implications of these findings for protective efficacy are not known.
Croatian: Implikacije ovih rezultata na zaštitnu djelotvornost nisu poznate.
English: See sections 4.4 and 5.1 for information on protection against specific pneumococcal serotypes.
Croatian: Vidjeti dijelove 4.4 i 5.1 za informacije o zaštiti od specifičnih pneumokoknih serotipova.
English: Tell your doctor or pharmacist if your child is taking, has recently taken or might take any other medicines, or if they have recently received any other vaccine.
Croatian: Obavijestite liječnika ili ljekarnika ako Vaše dijete uzima, nedavno je uzelo ili bi moglo uzeti bilo koje druge lijekove te ako je nedavno primilo neko drugo cjepivo.
English: This is usually in the thigh or upper arm.
Croatian: To je obično u bedro ili nadlakticu.
English: • your child has a severe infection with a high temperature (over 38 °C).
Croatian: • ako Vaše dijete ima tešku infekciju s visokom temperaturom (iznad 38°C).
English: Antipyretic treatment should be initiated according to local treatment guidelines.
Croatian: Terapija antipireticima treba se započeti prema lokalnim smjernicama za liječenje.
English: The persistence of protection against B-CAP and C-CAP beyond the age of 36 months is currently not established.
Croatian: Trajanje zaštite od B-CAP i C-CAP nakon navršenih 36 mjeseci nije još ustanovljeno.
English: Please speak to your doctor for information on the number and timing of injections for your child.
Croatian: Razgovarajte s liječnikom o broju i rasporedu injekcija za svoje dijete.
English: • temporarily stopping breathing (apnoea) if your child is born prematurely (before or at 28 weeks of pregnancy)
Croatian: • privremeni prekid disanja (apneja) ako je Vaše dijete prijevremeno rođeno (prije ili u 28. tjednu trudnoće)
English: At least six months after the last injection, your child will receive an additional injection (booster).
Croatian: Najmanje 6 mjeseci nakon zadnje injekcije dijete će primiti dodatnu injekciju (docjepljivanje).
English: • your child is allergic to the active substance, or any of the other ingredients of this vaccine (listed in section 6).
Croatian: • ako je Vaše dijete alergično na djelatnu tvar ili neki drugi sastojak ovog cjepiva (naveden u dijelu 6).
English: Clinical AOM
Croatian: Klinički AOM
English: (4) Individual serotypes for which statistical significance was reached in the effectiveness analysis controlling for confounding factors (no adjustment for multiplicity performed).
Croatian: (4) Pojedinačni serotipovi za koje je postignuta statistička značajnost u analizi učinkovitosti koja kontrolira zbunjujuće čimbenike (nije provedena prilagodba za umnoženost).
English: A minor infection such as a cold should not be a problem.
Croatian: Blagi oblik infekcije kao što je prehlada ne bi trebao biti problem.
English: Synflorix may not work as well if your child is taking medicines that affect the immune system to fight infection.
Croatian: Synflorix također ne mora dovoljno dobro djelovati ako Vaše dijete uzima lijekove koji mogu utjecati na imunološki sustav u borbi protiv infekcija.
English: Furthermore, 19,466 children and 116 preterm infants received a booster dose of Synflorix in the second year of life.
Croatian: Nadalje, 19 466 djece i 116 prijevremeno rođene dojenčadi primilo je dozu docjepljivanja cjepiva Synflorix u drugoj godini života.
English: Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or to any of the carrier proteins.
Croatian: Preosjetljivost na djelatne tvari ili neku od pomoćnih tvari navedenih u dijelu 6.1 ili na bilo koji od proteinskih nosača.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 30 March 2009
Croatian: Datum prvog odobrenja: 30. ožujka 2009.
English: Synflorix will only protect against infections caused by the bacteria for which the vaccine has been developed.
Croatian: Synflorix štiti samo od infekcija uzrokovanih bakterijama za koje je cjepivo razvijeno.
English: Table 5: Rates of IPD and the corresponding rate reductions in Finland IPD
Croatian: Tablica 5: Stope IPB-a i odgovarajuće stope smanjenja u Finskoj IPB
English: CI Confidence Interval
Croatian: CI interval pouzdanosti
English: It is used to help protect your child from 6 weeks up to 5 years of age against: a bacteria called ‘Streptococcus pneumoniae'.
Croatian: Primjenjuje se u svrhu zaštite Vašeg djeteta u dobi od 6 tjedana do 5 godina od: bakterije koja se naziva ‘Streptococcus pneumoniae'.
English: If not used within 28 days it should be discarded.
Croatian: Ako se ne primijeni u roku od 28 dana treba ga ukloniti.
English: It is important to follow the instructions from the doctor or nurse to complete the courses of injections.
Croatian: Važno je pratiti upute od liječnika ili medicinske sestre kako bi se ciklus davanja injekcija proveo u cijelosti.
English: Usually, your child (from 6 weeks to 6 months of age) will receive a course of 4 injections according to official recommendations or an alternative schedule may be used by the health care professional.
Croatian: Obično će Vaše dijete (u dobi od 6 tjedana do 6 mjeseci) primiti 4 injekcije u ciklusu prema službenim preporukama ili prema alternativnom rasporedu koji će preporučiti stručni zdravstveni djelatnik
English: The proportion of subjects who received the booster dose in the ATP cohort was 92.3% in both analyses.
Croatian: Udio ispitanika u ATP kohorti koji su primili dozu docjepljivanja iznosio je 92,3% u obje analize.
English: IPD due to individual serotypes(4) - 6B
Croatian: IPB izazvan pojedinačnim serotipovima(4) - 6B
English: Synflorix does not provide protection against other microorganisms.
Croatian: Synflorix ne pruža zaštitu od drugih mikroorganizama.
English: Contents of the pack and other information What Synflorix contains
Croatian: Sadržaj pakiranja i druge informacije Što Synflorix sadrži
English: Streptococcus pneumoniae and Non-Typeable Haemophilus influenzae (NTHi) are the most common causes of bacterial AOM worldwide.
Croatian: Streptococcus pneumoniae i netipizirani Haemophilus influenzae (NTHi) su najčešći uzročnici bakterijskog AOM-a širom svijeta.
English: Your doctor or nurse will inject your child with this vaccine.
Croatian: Liječnik ili medicinska sestra će primijeniti ovo cjepivo Vašem djetetu putem injekcije.
English: The results of the COMPAS study, which was performed in Latin America, should be interpreted with caution due to possible differences in epidemiology of pneumonia in different geographical locations.
Croatian: Rezultate ispitivanja COMPAS, koje je provedeno u Latinskoj Americi, treba tumačiti s oprezom zbog mogućih razlika u epidemiologiji upale pluća u različitim zemljopisnim područjima.
English: Immunogenicity in special population
Croatian: Imunogenost u posebnim populacijama
English: 7-valent Prevenar Difference in % ≥ 0.20µg/ml (7valent Prevenar minus Synflorix)
Croatian: Razlika u % ≥ 0,20 µg/ml (7valentni Prevenar minus Synflorix)
English: Safety was also assessed in 435 previously unvaccinated children from 2 to 5 years old of which 285 subjects received 2 doses of Synflorix.
Croatian: Sigurnost je također procjenjivana u 435 prethodno necijepljene djece u dobi od 2 do 5 godina, od kojih je 285 primilo 2 doze cjepiva Synflorix.
English: Do not administer intravascularly.
Croatian: Ne primjenjivati intravaskularno.
English: For other vaccine serotypes, the number of AOM cases was too limited to allow any efficacy conclusion to be drawn.
Croatian: Za ostale serotipove iz cjepiva broj slučajeva AOM-a bio je preograničen za izvođenje zaključka o djelotvornosti.
English: Synflorix should not be given if any of the above applies to your child.
Croatian: Synflorix se ne smije dati ako se nešto od gore navedenog odnosi na Vaše dijete.
English: As the benefit of vaccination is high in this group of infants, vaccination should not be withheld or delayed.
Croatian: S obzirom da je pozitivan učinak cijepljenja velik u ovoj skupini dojenčadi, cijepljenje se ne smije uskratiti niti odgađati.
English: In general, comparable vaccine responses were observed for the different schedules, although somewhat higher immune responses were noted for the 2-4-6 month schedule.
Croatian: Općenito, primijećeni su usporedivi odgovori na različite rasporede, iako je nešto snažniji imunološki odgovor zabilježen za raspored u dobi od 2-4-6 mjeseci.
English: • feeling irritable
Croatian: • osjećaj razdražljivosti
English: It is not known whether the reduction in antibody levels has an impact on the protection against pneumococcal disease.
Croatian: Nije poznato utječe li smanjenje razina protutijela na zaštitu protiv pneumokokne bolesti.
English: Preterm newborn infants (born between 27-36 weeks gestation)
Croatian: Prijevremeno rođena dojenčad (rođena između 27 i 36 tjedana gestacije)
English: It is important that procedures are in place to avoid injury from faints.
Croatian: Važno je da postoje utvrđene procedure kako bi se izbjegle ozljede prilikom nesvjestice.
English: • Synflorix is a turbid white suspension.
Croatian: • Synflorix je mutna bijela suspenzija.
English: The 10 pneumococcal serotypes included in this vaccine represent the major disease-causing serotypes in Europe covering approximately 56% to 90% of invasive pneumococcal disease (IPD) in children <5 years of age.
Croatian: Deset pneumokoknih serotipova, sadržanih u ovom cjepivu, predstavljaju glavne serotipove uzročnika bolesti u Europi, koji pokrivaju oko 56% do 90% invazivne pneumokokne bolesti (IPB) u djece mlađe od 5 godina.
English: Children with splenic dysfunction
Croatian: Djeca s poremećajima funkcije slezene
English: The vaccine is a turbid white suspension.
Croatian: Cjepivo je mutna bijela suspenzija.
English: Average follow-up, from first vaccination, was 24 to 28 months for invasive disease and hospital-diagnosed pneumonia.
Croatian: Prosječno vrijeme praćenja od prvog cijepljenja iznosilo je 24 do 28 mjeseci za invazivnu bolest i bolnički dijagnosticiranu upalu pluća.
English: In this age group, serotypes 1, 5 and 7F account for 3.3% to 24.1% of IPD depending on the country and time period studied.
Croatian: U ovoj dobnoj skupini, serotipovi 1, 5 i 7F su odgovorni za 3,3% do 24,1% IPB-a, ovisno o zemlji i ispitivanom vremenskom razdoblju.
English: • fits without temperature or due to high temperature (fever)
Croatian: • napadaji grčeva bez temperature ili zbog visoke temperature (vrućice)
English: Immunosuppressive therapy and immunodeficiency
Croatian: Imunosupresivna terapija i imunodeficijencija
English: Human data on the use during pregnancy or breast-feeding and animal reproduction studies are not available.
Croatian: Podaci o primjeni tijekom trudnoće ili dojenja u ljudi nisu dostupni, kao ni ispitivanja reprodukcije u životinja.
English: The recommended immunisation series to ensure optimal protection consists of four doses, each of 0.5 ml.
Croatian: Preporučeni raspored imunizacije koji osigurava optimalnu zaštitu sastoji se od četiri doze, svaka od 0,5 ml.
English: Results suggest comparable reactogenicity and safety profile of Synflorix between these high risk groups and healthy children.
Croatian: Rezultati upućuju na to da su reaktogenost i sigurnosni profil cjepiva Synflorix usporedivi u tim visokorizičnim skupinama i u zdrave djece.
English: Effectiveness against physician-diagnosed AOM reported by parents was studied in the nested study within the FinIP trial.
Croatian: Učinkovitost protiv liječnički dijagnosticiranog AOM-a koji su prijavili roditelji ispitivana je u ugniježđenom ispitivanju u sklopu ispitivanja FinIP.
English: Effectiveness/efficacy in infant cohort below 7 months of age at enrolment
Croatian: Učinkovitost/djelotvornost u kohorti dojenčadi mlađe od 7 mjeseci kod uključivanja
English: Information on protection conferred by the vaccine
Croatian: Informacije o zaštiti koju pruža cjepivo
English: Different injectable vaccines should always be given at different injection sites.
Croatian: Različita cjepiva u injekcijama moraju se uvijek primjenjivati na različitim ubodnim mjestima.
English: Pharmacotherapeutic group: vaccines, pneumococcal vaccines, ATC code: J07AL52
Croatian: Farmakoterapijska skupina: cjepiva, pneumokokna cjepiva, ATK oznaka: J07AL52
English: If a vaccine dose is withdrawn into a syringe for injection, the needle used for withdrawal must be replaced by a needle suitable for intramuscular injection.
Croatian: Ako je doza cjepiva povučena u štrcaljku za injekciju, potrebno je zamijeniti iglu upotrijebljenu za izvlačenje s iglom prikladnom za injekciju u mišić.
English: Table 3: Vaccine efficacy against AOM(1) in COMPAS
Croatian: Tablica 3: Djelotvornost cjepiva protiv AOM-a(1) u ispitivanju COMPAS
English: Official recommendations for the immunisation against diphtheria, tetanus and Haemophilus influenzae type b should also be followed.
Croatian: Također je potrebno slijediti službene preporuke za imunizaciju protiv difterije, tetanusa i Haemophilus influenzae tip b.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Croatian: • Periodička izvješća o neškodljivosti Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7. Direktive 2001/83/EZ i i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
English: As with all vaccines, Synflorix may not fully protect all children who are vaccinated.
Croatian: Poput svih ostalih cjepiva, Synflorix možda u potpunosti neće zaštititi svu cijepljenu djecu.
English: However, if your child gets any of these symptoms you should contact a doctor urgently.
Croatian: Međutim, ako se u Vašeg djeteta pojavi bilo koji od ovih simptoma, morate se hitno javiti liječniku.
English: The immunisation schedules for Synflorix should be based on official recommendations.
Croatian: Doziranje Raspored imunizacije cjepivom Synflorix mora se zasnivati na službenim preporukama.
English: Local reactogenicity of primary vaccination course was similar in infants < 12 months of age and in children > 12 months of age except for injection site pain for which the incidence increased with increasing age: pain was reported by more than 39% of the infants < 12 months of age and by more than 58% of the children > 12 months of age.
Croatian: Lokalna reaktogenost primarnog ciklusa cijepljenja bila je slična u dojenčadi < 12 mjeseci i u djece > 12 mjeseci, osim bolnosti na mjestu primjene cjepiva, za koju je incidencija rasla s porastom dobi: bolnost je prijavljena u više od 39% dojenčadi < 12 mjeseci i u više od 58% djece > 12 mjeseci.
English: Multidose vial For storage conditions after first opening of the medicinal product, see section 6.3.
Croatian: Za uvjete čuvanja nakon prvog otvaranja lijeka, vidjeti dio 6.3.
English: However, taken together there was a trend for decrease in overall pneumococcal carriage.
Croatian: Međutim, kada su se svi podaci pogledali zajedno, primijećen je trend smanjenja cjelokupnog kliconoštva pneumokoka.
English: 4-dose container 3 years
Croatian: 4-dozni spremnik 3 godine